Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
25.31
-0.30 (-1.17%)
At close: Sep 12, 2025, 4:00 PM EDT
25.42
+0.11 (0.43%)
After-hours: Sep 12, 2025, 6:52 PM EDT
Twist Bioscience Market Cap
Twist Bioscience has a market cap or net worth of $1.53 billion as of September 12, 2025. Its market cap has decreased by -42.21% in one year.
Market Cap
1.53B
Enterprise Value
1.37B
1-Year Change
-42.21%
Ranking
Category
Stock Price
$25.31
Market Cap Chart
Since October 31, 2018, Twist Bioscience's market cap has increased from $372.54M to $1.53B, an increase of 310.09%. That is a compound annual growth rate of 22.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 1.53B | -44.61% |
| Dec 31, 2024 | 2.76B | 29.75% |
| Dec 29, 2023 | 2.13B | 57.83% |
| Dec 30, 2022 | 1.35B | -64.93% |
| Dec 31, 2021 | 3.84B | -43.70% |
| Dec 31, 2020 | 6.82B | 881.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.45B |
| Johnson & Johnson | 423.36B |
| AbbVie | 373.87B |
| UnitedHealth Group | 314.07B |
| AstraZeneca | 250.26B |
| Novo Nordisk | 244.96B |
| Novartis AG | 244.56B |
| Abbott Laboratories | 225.15B |